Oklahoma medical board advertising rules: the 59 O.S. 509 and 637 guide
Oklahoma has two physician boards and two advertising standards. For M.D.s, 59 O.S. 509(6) makes "all advertising of medical business in which statements are made which are grossly untrue or improbable and calculated to mislead the public" unprofessional conduct. For D.O.s, 59 O.S. 637 covers advertising by means of knowingly false or deceptive statements and advertising under a name other than one's own.
- M.D.s are regulated by the Oklahoma State Board of Medical Licensure and Supervision; D.O.s by the Oklahoma State Board of Osteopathic Examiners.
- 59 O.S. 509(6) (M.D.s): all advertising of medical business with statements that are grossly untrue or improbable and calculated to mislead the public is unprofessional conduct.
- 59 O.S. 637 (D.O.s): advertising by means of knowingly false or deceptive statements, and advertising or practicing under a name other than one's own, are grounds for discipline.
- OAC 435:10-7-4 (M.D. board rule): false or misleading statements about skill or efficacy, claims an incurable condition can be cured, and giving or receiving fees for services not personally rendered.
- Dallas, Texas LLC
- 10-person US client team · Central Time (CST)
- 25+ US healthcare clients
- BAA signed with every client
- HIPAA compliance training across client and delivery teams
- Contracts and invoices in USD
-
Primary Care · North Dallas, TXCase study →
-
MedSpa · North Dallas, TX
-
Skin Care · Beverly Hills, CA
-
Dental · Christiansburg, VACase study →
-
Pediatrics · Blacksburg, VACase study →
-
Pediatric Dentistry · Blacksburg, VACase study →
-
Dental · Roanoke, VACase study →
-
Functional Medicine · Telehealth · USACase study →
“They were able to get all my ideas and work with me over a period of three to four months and create this amazing website. It's super customized, very modern, and it incorporates all the elements that I had wanted — the patient portal, nice pictures, a very interactive website, patient reviews. I would highly recommend their company to anyone who wants to make an excellent website.”
Which boards regulate Oklahoma healthcare advertising
Oklahoma splits physician regulation. The Oklahoma State Board of Medical Licensure and Supervision licenses M.D.s under the Oklahoma Allopathic Medical and Surgical Licensure and Supervision Act (59 O.S. 480 et seq.), with unprofessional conduct defined in 59 O.S. 509 and in the Board's rules at OAC 435:10-7-4. The Oklahoma State Board of Osteopathic Examiners licenses D.O.s under the Oklahoma Osteopathic Medicine Act, with disciplinary grounds in 59 O.S. 637.
A group with both M.D.s and D.O.s answers to both boards, so build creative to the stricter reading of each. Dentists are licensed by the Oklahoma Board of Dentistry.
59 O.S. 509, 59 O.S. 637 and OAC 435:10-7-4, explained
M.D.s: 59 O.S. 509
- (2) Obtaining or offering to accept any fee on the assurance or promise that a manifestly incurable disease can or will be cured.
- (3) Willfully betraying a professional secret to the detriment of the patient.
- (6) All advertising of medical business in which statements are made which are grossly untrue or improbable and calculated to mislead the public.
M.D.s: OAC 435:10-7-4
- (12) Making a false or misleading statement regarding skill or the efficacy or value of the medicine, treatment or remedy prescribed.
- (13) Representing to a patient that an incurable condition, sickness, disease or injury can be cured.
- (20) Practicing under a false or assumed name.
- (28) and (29) Obtaining fees by fraud or misrepresentation, and abusive billing practices.
- (30) Directly or indirectly giving or receiving any fee, commission, rebate or other compensation for professional services not actually and personally rendered.
The statute's "grossly untrue or improbable" wording sounds like a high bar, but the Board rule's "false or misleading statement regarding skill or the efficacy" is a lower one. Write to the rule.
D.O.s: 59 O.S. 637
The osteopathic grounds include having been guilty of advertising by means of knowingly false or deceptive statements, and of advertising, practicing or attempting to practice under a name other than one's own.
Allowed, prohibited, needs disclosure: the Oklahoma working table
How we apply Oklahoma law on pre-publication reviews for M.D. and D.O. practices.
| Creative element | Status | Practical rule and basis |
|---|---|---|
| Efficacy or skill claims | Needs substantiation | False or misleading statements about skill or efficacy (OAC 435:10-7-4(12)); improbable claims (509(6)). |
| "Guaranteed cure" | Prohibited | Fees on promise of curing a manifestly incurable disease (509(2)); incurable-cure claims (435:10-7-4(13)). |
| Brand or DBA without the physician's name | Needs review | D.O.s: advertising under a name other than one's own (637). M.D.s: false or assumed name (435:10-7-4(20)). Tie brands to licensed physicians. |
| Per-patient referral or lead fees | High risk | Giving or receiving compensation for services not personally rendered (435:10-7-4(30)). Get legal review. |
| Testimonials and review replies | Allowed with care | No betrayal of professional secrets (509(3)); HIPAA authorization; FTC disclosures. |
| Price promotions | Allowed with care | State conditions; no fraud or abusive billing (435:10-7-4(28), (29)). |
| Board certification | Allowed if accurate | Name the board; a false credential is a deceptive statement. |
What is different about Oklahoma
Two boards, two standards
The M.D. and D.O. statutes are worded differently. The osteopathic ground speaks of "knowingly" false or deceptive statements; the allopathic statute speaks of "grossly untrue or improbable" statements "calculated to mislead", backed by a Board rule on false or misleading statements about skill or efficacy. In a mixed group, apply the stricter reading to everyone.
Names and brands
Advertising under a name other than one's own is listed for D.O.s. Clinic brands are common and generally workable, but each brand should be clearly tied to the licensed physicians who practice under it.
Confidentiality
59 O.S. 509(3) lists willfully betraying a professional secret to the detriment of the patient. Review replies and case stories that reveal treatment details without consent can create risk under this ground as well as HIPAA.
How federal rules layer on top of Oklahoma law
Oklahoma board rules sit on top of a federal floor that applies to every US practice. In short:
- FTC Act and the Endorsement Guides (16 CFR Part 255). Claims need a reasonable basis before they run. Reviews, testimonials and influencer posts must reflect real experience, and any material connection (payment, free treatment, staff or family ties) must be disclosed clearly. If results shown are not what patients generally get, say what they can generally expect.
- FTC rule on consumer reviews and testimonials (16 CFR Part 465, effective October 21, 2024). Bans fake or AI-invented reviews, buying positive reviews, undisclosed insider reviews and review suppression, with civil penalties available per violation.
- HIPAA marketing rule (45 CFR 164.501 and 164.508(a)(3)). Using a patient's protected health information in marketing (a named testimonial, a before-and-after photo, a case story) generally needs the patient's signed written authorization. Replying to an online review in a way that confirms someone is a patient can be an impermissible disclosure. Tracking pixels on pages that collect health information need a careful look too. See our HIPAA-compliant healthcare marketing guide.
- TCPA (47 U.S.C. 227; 47 CFR 64.1200). Marketing texts and autodialed or prerecorded calls to mobile phones need prior express written consent. Keep the consent record and honor opt-outs.
- CAN-SPAM. Marketing email needs an accurate sender, a non-deceptive subject line, a physical address and a working unsubscribe.
Platform policies (Google Ads healthcare and medicines policy, Meta's health and wellness ad rules) are a further layer. They can reject an ad that is lawful in Oklahoma, so plan creative to clear all three: state rule, federal rule, platform rule.
Oklahoma compliance checklist for website, ads, social and reviews
Website and provider pages
Physician bios show M.D. or D.O. and the certifying board. Brand pages name the licensed physicians. Efficacy statements are supported and not overstated.
Paid search and paid social
Remove guaranteed or improbable outcome claims. Make sure ads for D.O. practices use the physician's own name or a brand clearly tied to it. Review vendor pay structures.
Organic social and influencers
Disclose every material connection on the post itself (#ad or "paid partnership", plus free treatment or discounts). Get a HIPAA authorization before posting any patient image or story. Keep result claims to what patients generally achieve.
Reviews and reputation
Ask every patient the same way, never pay or discount for a review, and never gate or suppress negative ones. Reply without confirming that the reviewer is a patient or discussing their care; move details offline.
Two-board review
For mixed M.D./D.O. groups, review each campaign against both 59 O.S. 509 / OAC 435:10-7-4 and 59 O.S. 637.
Substantiation file
For every factual claim (years in practice, procedure counts, certifications, "first" or "only" claims), keep a dated record of the evidence. Review the file when credentials, staff or services change.
Oklahoma medical advertising: common questions
Which Oklahoma law covers M.D. advertising?
59 O.S. 509(6), which makes advertising with grossly untrue or improbable statements calculated to mislead the public unprofessional conduct, together with the Board rule OAC 435:10-7-4.
Which Oklahoma law covers D.O. advertising?
59 O.S. 637, which lists advertising by knowingly false or deceptive statements and advertising under a name other than one's own as grounds for discipline by the Oklahoma State Board of Osteopathic Examiners.
Can Oklahoma physicians pay for patient referrals?
OAC 435:10-7-4(30) lists giving or receiving compensation for professional services not actually and personally rendered as unprofessional conduct. Get legal advice before any per-patient marketing fee.
Can I promise a cure in Oklahoma ads?
No. Fees on the promise that a manifestly incurable disease can be cured (59 O.S. 509(2)) and representing an incurable condition can be cured (OAC 435:10-7-4(13)) are both listed.
Do Oklahoma rules restrict testimonials?
We found no specific testimonial ban. Testimonials must not be misleading, must not reveal confidential details without consent, and need a HIPAA authorization and FTC-compliant disclosures.
Sources
Official Oklahoma sources first, then federal. Where an official site blocked automated access, we confirmed the text through a published copy of the same section and say so below.
- 59 O.S. 509 and 59 O.S. 637 as reprinted in HB 1102 (2021), as introduced (Oklahoma Legislature, PDF)
- OAC 435:10-7-4, Unprofessional conduct (Cornell LII copy)
- Oklahoma State Board of Medical Licensure and Supervision
- Oklahoma State Board of Osteopathic Examiners
- FTC Guides Concerning the Use of Endorsements and Testimonials in Advertising, 16 CFR Part 255 (eCFR)
- FTC Trade Regulation Rule on the Use of Consumer Reviews and Testimonials, 16 CFR Part 465 (eCFR)
- Final rule notice, 89 Fed. Reg. (August 22, 2024), effective October 21, 2024 (GovInfo)
- HIPAA Privacy Rule, uses and disclosures requiring authorization, 45 CFR 164.508 (eCFR)
- HIPAA Privacy Rule definitions including "marketing", 45 CFR 164.501 (eCFR)
- TCPA implementing rules, 47 CFR 64.1200 (eCFR)
Neighboring states and next reads
Get your Oklahoma marketing checked before it runs
Book a call with the Ichelon Consulting US team in Dallas (Central Time). We review your website, ads and review responses against the Oklahoma rules above and the federal layer, then fix what needs fixing. Every US client signs a BAA with us; our client-facing team holds HIPAA compliance training certificates. Retainers are custom-scoped, from $499/month.